Skip to content. | Skip to navigation

Garvan Institute

Sections
 

Cell Cycle

 

Group Leader
Associate Professor Liz Musgrove

 

Female steroid hormones like oestrogen and progesterone strongly influence cell reproduction in the breast. We are particularly interested in how these hormones act on the cell cycle machinery and how control over the cell cycle is lost in breast cancer cells. Since the cell cycle gene cyclin D1 is frequently overexpressed in breast cancer, we have been studying genes that act upstream of cyclin D1. In collaboration with the Steroid Hormone Action and Breast Cancer Translational Groups, we are also searching for new genes that might link oestrogen action with the cell cycle and so could be involved in resistance to the anti-oestrogen medication, tamoxifen, in the clinic.

Staff

christine_lee90.jpgResearch Assistant
Christine Lee
Marcello SergioResearch Assistant
Marcelo Sergio
liz_caldonResearch Officer
Elizabeth Caldon
Visiting Student
Judith Schuette



News

 

Calculating how breast cancers will respond to tamoxifen

MEDIA RELEASE: 08 Sep 2008
A discovery by Garvan scientists should help clinicians decide which women with breast cancer will make good candidates for anti-oestrogen therapies, such as tamoxifen, and which will not.
 
 

Personal tools